JP2007532495A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532495A5
JP2007532495A5 JP2007506658A JP2007506658A JP2007532495A5 JP 2007532495 A5 JP2007532495 A5 JP 2007532495A5 JP 2007506658 A JP2007506658 A JP 2007506658A JP 2007506658 A JP2007506658 A JP 2007506658A JP 2007532495 A5 JP2007532495 A5 JP 2007532495A5
Authority
JP
Japan
Prior art keywords
use according
ghrelin
individual
medicament
thyroiditis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007506658A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532495A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2005/000237 external-priority patent/WO2005097173A2/en
Publication of JP2007532495A publication Critical patent/JP2007532495A/ja
Publication of JP2007532495A5 publication Critical patent/JP2007532495A5/ja
Withdrawn legal-status Critical Current

Links

JP2007506658A 2004-04-07 2005-04-07 グレリン欠乏を治療するための分泌促進薬の使用 Withdrawn JP2007532495A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400569 2004-04-07
DKPA200401656 2004-10-27
PCT/DK2005/000237 WO2005097173A2 (en) 2004-04-07 2005-04-07 Use of ghrelin for the treatment of hyperthyroidism

Publications (2)

Publication Number Publication Date
JP2007532495A JP2007532495A (ja) 2007-11-15
JP2007532495A5 true JP2007532495A5 (https=) 2008-05-08

Family

ID=34981499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506658A Withdrawn JP2007532495A (ja) 2004-04-07 2005-04-07 グレリン欠乏を治療するための分泌促進薬の使用

Country Status (5)

Country Link
US (1) US20080171700A1 (https=)
EP (1) EP1742655A2 (https=)
JP (1) JP2007532495A (https=)
CA (1) CA2603295A1 (https=)
WO (1) WO2005097173A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045314A2 (en) * 2004-10-27 2006-05-04 Gastrotech Pharma A/S Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease
KR101510082B1 (ko) * 2006-08-01 2015-04-10 더 스크립스 리서치 인스티튜트 비만증을 억제하기 위한 백신 및 방법
DK2118123T3 (en) 2007-01-31 2016-01-25 Dana Farber Cancer Inst Inc Stabilized p53 peptides and uses thereof
CN101657436A (zh) 2007-02-09 2010-02-24 特兰齐姆制药公司 大环生长素释放肽受体调节剂及其使用方法
US8592377B2 (en) 2007-03-28 2013-11-26 President And Fellows Of Harvard College Stitched polypeptides
JP5486690B2 (ja) 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ メラノコルチン受容体リガンドの医薬組成物
CN102821775B (zh) * 2010-03-15 2014-10-22 益普生制药股份有限公司 生长激素促分泌素受体配体的药物组合物
ES2711526T3 (es) 2010-08-13 2019-05-06 Aileron Therapeutics Inc Macrociclos peptidomiméticos
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
BR112014020103A2 (pt) 2012-02-15 2018-10-09 Aileron Therapeutics, Inc. macrociclos peptidomiméticos
EP2819688A4 (en) 2012-02-15 2015-10-28 Aileron Therapeutics Inc TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
BR112015006282B1 (pt) * 2012-09-27 2021-11-23 Aratana Therapeutics, Inc Composições e usos de capromorelina para controle de inapetência
WO2014054798A1 (ja) * 2012-10-04 2014-04-10 独立行政法人国立循環器病研究センター 悪性腫瘍転移抑制用医薬
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
WO2015066490A1 (en) * 2013-10-31 2015-05-07 Ohio University Prevention and treatment of non-alcoholic fatty liver disease
US10392381B2 (en) 2014-07-18 2019-08-27 Ohio University Prevention and treatment of non-alcoholic fatty liver disease
EP3197478A4 (en) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
KR20200121308A (ko) * 2018-02-14 2020-10-23 루모스 파마, 인크. 비알코올성 지방간 질환 및 비알코올성 지방간염 치료용 조성물
CN110859953B (zh) * 2019-10-26 2025-08-12 沈阳医学院 Ghrh-a在制备治疗非酒精性脂肪性肝病药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US605853A (en) * 1898-06-21 caude
US26252A (en) * 1859-11-29 Harness-yoke
US501403A (en) * 1893-07-11 Richard brayton
US48623A (en) * 1865-07-04 wilson hodges
US192292A (en) * 1877-06-19 Improvement in malting of grain
US134593A (en) * 1873-01-07 Improvement in chair seats and backs
US305138A (en) * 1884-09-16 Sash-fastener
US403295A (en) * 1889-05-14 Machine for coating or impregnating bags with wax
US1060190A (en) * 1912-09-20 1913-04-29 Franklin Knitting Mills Knitted necktie.
US1197496A (en) * 1914-06-30 1916-09-05 Richard Jobling Expansible pipe and joint.
CZ20011309A3 (cs) * 1998-11-03 2001-10-17 Novo Nordisk A/S Sloučeniny s vlastnostmi uvolňování růstového hormonu
JP2002542151A (ja) * 1999-02-18 2002-12-10 科研製薬株式会社 成長ホルモン分泌促進物質としての新規なアミド誘導体
ES2401939T3 (es) * 1999-07-23 2013-04-25 Kenji Kangawa Nuevos péptidos
US6967237B2 (en) * 2000-05-30 2005-11-22 Merck & Co., Inc. Ghrelin analogs
AU2002351593A1 (en) * 2001-12-18 2003-06-30 Theratechnologies Inc. Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
EP1407779A1 (en) * 2002-10-10 2004-04-14 Gastrotech A/S Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
EP1660117A2 (en) * 2003-08-06 2006-05-31 Gastrotech Pharma A/S Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite

Similar Documents

Publication Publication Date Title
JP2007532495A5 (https=)
RU2678833C2 (ru) Фармацевтические композиции и соответствующие способы доставки
CN1293916C (zh) 稳定的胰岛素制剂
US20080090753A1 (en) Rapid Acting Injectable Insulin Compositions
Sinko et al. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin
JP2021503468A5 (https=)
US20120288531A1 (en) pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
GB2112641A (en) The use of peptides as medicaments
US20250170218A1 (en) Stable pharmaceutical composition of receptor agonist, and preparation method and application thereof
US8664268B2 (en) Gallium compositions for the treatment of liver cancer and methods of use
Stöckmann et al. Long-term treatment of patients with endocrine gastrointestinal tumours with the somatostatin analogue SMS 201-995
Carlsson et al. The long-acting somatostatin analogue octreotide decreases pancreatic islet blood flow in rats
EP3871692B1 (en) Pharmaceutical composition with blood sugar lowering effect
Petersen et al. Superiority of tetraethylammonium to p-aminohippurate as a marker for renal plasma flow during furosemide diuresis
CN101282741B (zh) 治疗或预防缺血性再灌注损伤或多器官衰竭的方法
Edelman et al. Quantification of insulin release from implantable polymer‐based delivery systems and augmentation of therapeutic effect with simultaneous release of somatostatin
US12343383B2 (en) High concentration insulin formulation
JP2013501043A5 (https=)
CN1511037A (zh) 非肠道使用的雌莫司汀磷酸盐和白蛋白的制剂
CN113509544B (zh) 一种具有降血糖作用的药物组合物
Harano et al. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis
JPH0242027A (ja) 経粘膜吸収促進剤及びこれを用いた経鼻投与剤
HK40128412A (zh) 糖尿病的治疗
Reboredo-Fuentes et al. Oral administration of zein-based nanoparticles reduces glycemia and improves glucose tolerance in rats
US20260014233A1 (en) Multi-dose pen of tirzepatide